What would be your next step in treating a patient with osteoporosis who developed AFF on denosumab and who then completed one year of romosozumab?  

There is no evidence-based answer for this question. First of all, the development of AFF while on osteoporosis doses of denosumab is very rare. It usually occurs in people who have previously been on bisphosphonates. I would most appropriately assess fracture risk after the romo and then determine ...

Agree.

I thought anabolics were not recommended after Denosumab.